Krajina: Austrália
Jazyk: angličtina
Zdroj: APVMA (Australian Pesticides and Veterinary Medicines Authority)
POTASSIUM ASPARTATE; MAGNESIUM ASPARTATE; HEPTAMINOL HYDROCHLORIDE; SODIUM SELENITE; DISODIC ADENOSINE MONOPHOSPHATE; VITAMIN B12 = CYANOCOBALAMIN
Vetoquinol Australia Pty Ltd
heptaminol HCl(5g/L)+disodium adenosine monophosp(2g/L) + others
PARENTERAL LIQUID/SOLUTION/SUSPENSION
POTASSIUM ASPARTATE AMINO ACID-ASPARTATE Active 1.0 g/100ml; MAGNESIUM ASPARTATE AMINO ACID-ASPARTATE Active 1.5 g/100ml; HEPTAMINOL HYDROCHLORIDE AMINE/AMIDE Active 0.5 g/100ml; SODIUM SELENITE MINERAL-SELENIUM Active 0.05 g/100ml; DISODIC ADENOSINE MONOPHOSPHATE NUCLEOTIDE Active 0.2 g/100ml; VITAMIN B12 = CYANOCOBALAMIN VITAMIN-B12 Active 0.025 g/100ml
100mL
VM - Veterinary Medicine
DOG | HORSE | BITCH | CASTRATE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT
NUTRITION & METABOLISM
MUSCULAR DYSTROPHY | MUSCULAR STIMULANT | TYING-UP SYNDROME (HORSES)
Poison schedule: 6; Withholding period: WHP:Meat- Nil; Host/pest details: DOG: [MUSCULAR DYSTROPHY]; HORSE: [MUSCULAR DYSTROPHY]; Poison schedule: 6; Withholding period: ; Host/pest details: DOG: [MUSCULAR DYSTROPHY]; HORSE: [MUSCULAR DYSTROPHY]; An aid in the control of muscular dystrophy in horses and dogs (tying up syndrome in horses).
Stopped
2020-07-01
Kynoselen - Muscular stimulant for horses and dogs draft label 41608/0901 100mL vial and box page 1 of 4 May 2016 _Vial main panel _ POISON KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Kynoselen ® - Muscular stimulant for horses and dogs ACTIVE CONSTITUENTS (per 100mL): HEPTAMINOL HYDROCHLORIDE 0.50g DISODIC ADENOSINE MONOPHOSPHATE 0.20g 0.05g 1.50g 1.00g SODIUM SE LENITE MAGNESIUM AS PARTATE POTASSIUM ASPARTATE CYANOCOBALAMIN 0.025g Intramuscular or Subcutaneous Injectable Solution An aid in the control of muscular dystrophy in horses and dogs (tying-up syndrome in horses) 100mL APPROVED NON-RLP AMENDMENT MADE Kynoselen - Muscular stimulant for horses and dogs draft label 41608/0901 100mL vial and box page 2 of 4 May 2016 _Vial ancillary panel 1 _ DIRECTIONS FOR USE Treatment: 1 injection once every 3 days for 9 to 12 days. Prevention: 1 injection once a week for 2 to 3 weeks. Horses: Adult 20mL. Foals: 10mL Dogs: 2 to 5mL according to size by subcutaneous or intramuscular route. If used in performance animals, the regulations of the relevant authorities regarding medication should be observed. MEAT WITHHOLDING PERIOD: NIL _Vial ancillary panel 2 _ Manufactured by: Vétoquinol S.A. 70204 LURE Cedex (France) Distributed by: _ _ VETOQUINOL AUSTRALIA Pty Ltd ABN 64 006 949 480 Unit 302. 2 , 6-12 Boronia Road, Da Vinci Business Park, Brisbane Airport, Qld, 4008 Tel : 1800 035 355 Email : sales.australia@vetoquinol.com Store below 25°C (Air conditioning). Protect from light. Dispose of empty container by wrapping with paper and putting in garbage. NRA Approval No. 41608/0901 Batch: Expiry: [packaging ID] Kynoselen - Muscular stimulant for horses and dogs draft label 41608/0901 100mL vial and box page 3 of 4 May 2016 _Box main panel _ POISON KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Kynoselen ® - Muscular stimulant for horses and dogs ACTIVE CONSTITUENTS (per 100mL): HEPTAMINOL HYDROCHLORIDE 0.50g DISODIC ADENOSINE MONOPHOSPHATE 0.20g 0.05g 1.50g 1.00g SODIUM SE LENITE MAGNESIUM AS PARTATE Prečítajte si celý dokument
PRODUCT NAME: KYNOSELEN® MUSCULAR STIMULANT FOR HORSES AND DOGS PAGE: 1 OF 4 THIS REVISION ISSUED: OCTOBER, 2008 MATERIAL SAFETY DATA SHEET ISSUED BY: AUSRICHTER PTY LTD PHONE: 02 9517 1166 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY AUSRICHTER PTY LTD PHONE: 02 9517 1166 2/21 CHESTER ST FAX: 02 9516 5810 CAMPERDOWN NSW 2050 AUSRICHTER@BIGPOND.COM SUBSTANCE: Blend of ingredients in water solution; presented as an injectable solution. TRADE NAME: KYNOSELEN ® MUSCULAR STIMULANT FOR HORSES AND DOGS PRODUCT USE: An aid in the control of muscular dystrophy in horses and dogs (tying-up syndrome in horses) for use as described on the product label. CREATION DATE: OCTOBER, 2008 REVISION DATE: OCTOBER, 2008 SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of ASCC. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: R33. Danger of cumulative effects. SAFETY PHRASES: S24/25. Avoid contact with skin and eyes. SUSDP CLASSIFICATION: S6 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated EMERGENCY OVERVIEW PHYSICAL DESCRIPTION & COLOUR : Red liquid. ODOUR: Slight alcohol-like odour. MAJOR HEALTH HAZARDS: danger of cumulative effects. POTENTIAL HEALTH EFFECTS On injection, heptaminol has an adrenalin-like action in horses. 20g heptaminol is equivalent to the action produced by 0.5mg adrenalin. INHALATION: SHORT TERM EXPOSURE: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. Prečítajte si celý dokument